Health
Antiviral proves effective at preventing, treating COVID-19 in lab – EurekAlert
Publishing their work in Nature, scientists at the UNC School of Medicine and UNC Gillings School of Global Public Health tested how the orally administered experimental…
CHAPEL HILL, NC – Publishing their work in Nature, scientists at the UNC School of Medicine and UNC Gillings School of Global Public Health found that the orally administered experimental drug EIDD-2801 halts SARS-CoV-2 replication and prevents infection of human cells in a new in vivo lab model containing human lung tissue.
Separate phase 2 and 3 clinical trials are ongoing to evaluate EIDD-2801 safety in humans and its effect on viral shedding in COVID-19 patients.
The number of new COVID-19…
-
Noosa News12 hours agoTwo teenagers and two adults rushed to hospital in life-threatening conditions after shocking Lawnton house fire
-
Noosa News13 hours agoA secret scheme and plans to expel former leaders — here’s what we’ve heard from Queensland’s inquiry into the CFMEU
-
Noosa News12 hours agoFatal traffic crash, Noosa – Sunshine Coast
-
Business12 hours agoTop brokers name 3 ASX shares to buy next week 23 November 2025